1. Home
  2. BNTC vs KOPN Comparison

BNTC vs KOPN Comparison

Compare BNTC & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • KOPN
  • Stock Information
  • Founded
  • BNTC 1995
  • KOPN 1984
  • Country
  • BNTC United States
  • KOPN United States
  • Employees
  • BNTC N/A
  • KOPN N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • BNTC Health Care
  • KOPN Technology
  • Exchange
  • BNTC Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • BNTC 88.1M
  • KOPN 85.7M
  • IPO Year
  • BNTC N/A
  • KOPN 1992
  • Fundamental
  • Price
  • BNTC $11.82
  • KOPN $1.31
  • Analyst Decision
  • BNTC Buy
  • KOPN Strong Buy
  • Analyst Count
  • BNTC 6
  • KOPN 3
  • Target Price
  • BNTC $23.83
  • KOPN $2.67
  • AVG Volume (30 Days)
  • BNTC 53.1K
  • KOPN 1.5M
  • Earning Date
  • BNTC 02-11-2025
  • KOPN 11-12-2024
  • Dividend Yield
  • BNTC N/A
  • KOPN N/A
  • EPS Growth
  • BNTC N/A
  • KOPN N/A
  • EPS
  • BNTC N/A
  • KOPN N/A
  • Revenue
  • BNTC N/A
  • KOPN $44,266,305.00
  • Revenue This Year
  • BNTC N/A
  • KOPN $22.10
  • Revenue Next Year
  • BNTC N/A
  • KOPN $14.34
  • P/E Ratio
  • BNTC N/A
  • KOPN N/A
  • Revenue Growth
  • BNTC N/A
  • KOPN 0.60
  • 52 Week Low
  • BNTC $2.69
  • KOPN $0.56
  • 52 Week High
  • BNTC $13.29
  • KOPN $2.82
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 62.51
  • KOPN 69.76
  • Support Level
  • BNTC $11.36
  • KOPN $1.03
  • Resistance Level
  • BNTC $13.29
  • KOPN $1.29
  • Average True Range (ATR)
  • BNTC 0.96
  • KOPN 0.11
  • MACD
  • BNTC 0.23
  • KOPN 0.00
  • Stochastic Oscillator
  • BNTC 86.05
  • KOPN 71.79

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference with gene therapy for providing sustained, long-lasting silencing of disease-causing genes from a single administration. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The company is developing product candidates in chronic and life-threatening human disease areas including Orphan disease: Oculopharyngeal Muscular Dystrophy (OPMD) and Infectious disease: Hepatitis B Virus (HBV). BB-301 is currently under development by the group; it is designed to slow, or halt, the disease progression.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: